Definition of Xeroderma Pigmentosum: XP XP, first described in 1874, is a rare genetic defect in the nucleotide excision repair mechanism. It is characterized.

Slides:



Advertisements
Similar presentations
About XP Xeroderma pigmentosum was first described in 1874 by Hebra and Kaposi. In 1882, Kaposi coined the term xeroderma pigmentosum for the condition,
Advertisements

Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
DNA Repair Nucleotide Excision Repair XP and CS BiS222 By Jooyoung Chang 장주영 Class #01 / Stu. #
DNA repair. spontaneous vs. induced mutation gametic vs. somatic mutation lethal or conditional mutation Classification of the mutation.
Jordan A. Mays. Key Points: 8 XP family proteins repair DNA damaged by sunlight through Nucleotide Excision Repair. XPF-ERCC1 complex is a structure-specific.
Etiology Of Cancer &Carcinogenic Agents
Lecture 11: Signalling for Life/Death 1)Describe the eukaryotic cell cycle and the purpose of checkpoints. 2)Describe the role of cyclins and cyclin-dependent.
Cancer- A Deeper Look (Part 4) Ms. Gaynor Honors Genetics.
CANCER IS A GENETIC DISEASE SUPPORTING EVIDENCE: 1. Hereditary cancer 2. Cancer-causing virus 3. Alterations of cellular genes in cancer 4. Clonal development.
XERODERMA PIGMENTOSUM XPF and Nucleotide Excision Repair Sapna Patel
Xeroderma Pigmentosum, XPF and Nucleotide Excision Repair By Crystal Stanford.
34 Cancer.
Genetica per Scienze Naturali a.a prof S. Presciuttini 1. One-to-many relationship of phenotypes to genes This concept is based on the observation.
Xeroderma Pigmentosum Nov 21st 2005 Diana Mok Kaitlin Myers Thao Nguyen T. Nguyen.
BioSci 145A lecture 18 page 1 © copyright Bruce Blumberg All rights reserved BioSci 145A Lecture 18 - Oncogenes and Cancer Topics we will cover today.
Molecular Pathology – Cell cycle Dr. Leonard Da Silva Senior Lecturer Molecular & Cellular Pathology.
Karp/CELL & MOLECULAR BIOLOGY 3E
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
Outline What is cancer? How do people know they have cancer?
XPF Nucleotide Excision Repair. Xerderma Pigmentosum (XP) UV Light Sensitivity Early Age Freckling Severe Sunburning Keratosis Neurological defects Non-melonoma.
21 and 23 March, 2005 Chapter 15 Regulation of Cell Number: Normal and Cancer Cells Regulated and unregulated cell proliferation.
Nermeen Jouda Bch 550 Supervised by Dr Gihan.
Control of skin cancer by the circadian rhythm Background presented by Nathalie Javidi-Sharifi Druker Lab.
Cancer Cell cycle, oncogenes and tumour suppressors Jake Turner.
Journal Club 5/14/15 Dysregulation of Gene Expression as a Cause of Cockayne Syndrome Neurological Disease. Wang Y, et al. PNAS
Gene Mutations.
GROUP 4.
By the end of this lecture, students will learn: 1.Oncogenes 2.Tumor suppressor genes. 3.DNA Repair genes 4.Genes Associated with Cancer Intended Learning.
DNA Repair and Cancer. Genome Instability Science, 26 July 2002, p. 544.
NOTES: CH 18 part 2 - The Molecular Biology of Cancer
3.1.3.A Understanding Cancer What is Cancer.
DNA Repair Uracil-DNA Glycosylase. DNA is continually assaulted by damaging agents (oxygen free radicals, ultraviolet light, toxic chemicals). Fortunately,
Which of the following functions are accomplished by cell division? a) growth, communication, and development b) growth, repair, and reproduction c) development,
CANCER Definition Abnormal growth of cells that invade tissues and spread to other sites. Cell Regulation Normal Mitosis Reproduction occurs only when.
Nucleotide Excision Repair ( NER ) 核苷酸切除修理 Nucleotide excision repair ( NER ) operates by a cut-and-patch mechanism that removes a variety of bulky lesions.
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
Xeroderma Pigmintosum (XP). Group Leader : 93-Esraa Samy Faried Abdelghafar. Members : 91-Esraa Raafat Ahmed Ahmed. 92-Esraa Reda Hashem Tewfik. 94-Esraa.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Chapter 12: The Cell Cycle
Benign Versus Malignant Tumors
Dr. Saleem Shaikh NEOPLASIA - II. Majority of the neoplasms are categorised clinically and morphologically into benign and malignant on basis of certain.
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Section S Tumor viruses and oncogenes
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
PHL 472 Chemical Carcinogens Abdelkader Ashour, Ph.D. 2 nd Lecture.
Types of Genes Associated with Cancer
Xeroderma Pigmentosum (XPF) Cara Mitchell. Characteristics of XP  Extreme photosensitivity  Early onset of skin cancers  Blistering of skin from sun.
Dr.Aida Fadhel Biawi 2014 Mechanisms of DNA repair.
Meccanismi di riparazione Donata Orioli
CANCER MODULE Units 1.3, 2.2, 2.3, 2.4, 2.5. REGULATION OF THE CELL CYCLE Drivers Checkpoints Divide!!Don’t divide!!
Skin Cancer. Skin Cancer: The Facts The most common cancer in the United States – Approximately 2 million people are diagnosed annually The number one.
The Genetic Basis of Cancer
CANCER What do you need to know??
Regulation of the Cell Cycle & Cancer
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Peter John M.Phil, PhD Atta-ur-Rahman School of Applied Biosciences (ASAB) National University of Sciences & Technology (NUST)
Xeroderma Pigmentosum, XPF
Tumor Promoting Inflammation
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
B lymphocytes produce antibodies.
Cancer.
The Cell Cycle and Understanding Cancer
Cancer- A Deeper Look (Part 4)
M.B.Ch.B, MSC, DCH (UK), MRCPCH
Oxidative and Energy Metabolism as Potential Clues for Clinical Heterogeneity in Nucleotide Excision Repair Disorders  Mohsen Hosseini, Khaled Ezzedine,
Characterization of Three XPG-Defective Patients Identifies Three Missense Mutations that Impair Repair and Transcription  Annika Schäfer, Steffen Schubert,
Volume 36, Issue 4, Pages (November 2009)
Shining a Light on Xeroderma Pigmentosum
Presentation transcript:

Definition of Xeroderma Pigmentosum: XP XP, first described in 1874, is a rare genetic defect in the nucleotide excision repair mechanism. It is characterized by hypersensitivity to the ultraviolet portion of sunlight.

Symptoms of XP: increased skin and eye cancers early onset of freckling blistering with minimal sun exposure blindness and deafness dwarfism and hypergonadism mental retardation

Basic Statistics on XP: XP is an autosomal recessive disease XP patients are 1000 times as susceptible to sunlight induced skin cancers About 1 person in 100,000 has the disease It effects both young and old, although the disease is usually diagnosed at a very early age.

Skin Cancer Rates in XP Patients

CANCER ETIOLOGY DNA damage causes mutations that activate oncogenes or inactivate tumor suppressor genes.

Oncogenes Growth factor receptors Protein tyrosine kinases (e.g., ras and src) Transcription factors (e.g., Fos, Jun, Myc)

Tumor suppressor genes Cell cycle control and apoptosis p53 (“guardian of the cell”) p21 and p16 (CDK inhibitors) Rb (negative regulator of E2F) DNA repair

XP is characterized by an inability of a cell to repair damage caused by UV leading to genetic instability and skin cancer.

Nucleotide Excision Repair or (NER) This system is responsible for removing the damaged segments of DNA and restoring the original sequence of DNA. The NER mechanism is composed of two types: global genome (GGR) and transcription coupled (TCR) Seven XP genes are central to NER which includes many other accessory proteins.

Complementation Groups for XP: XPA XPB XPC XPD XPE XPF XPG

DNA damage recognition: XPA and XPC are both damage-recognition proteins and are considered the “classical” forms of XP. (XPE is probably also involved in damage recognition)

Current Model for Mammalian NER

DNA damage accessibility : XPB and XPD are topoisomerases that unwind the damaged region of DNA. They are components of the general transcription factor TFIIH. Defects in XPB or XPD lead to the developmental and neurological symptoms of XP (e.g., dwarfism, hypogonadism, etc.)

Current Model for Mammalian NER

DNA incision enzymes: XP-F and XP-G are responsible for making incisions at either side of the damage, leading to the release of a 29 base fragment including the damaged bases.

Current Model for Mammalian NER

Evidence supporting UVB damage to XPA repair gene: A group of scientist at the University of Utrecht, The Netherlands did an experiment involving transgenic mice in which the XPA gene had been “knocked out.”. The three groups of mice they studied had functional XPA (XPA +/+), were heterozygous for XPA ( XPA +/-), or had nonfunctional XPA ( XPA -/-). The purpose of the experiment was to compare the effects of UVB light and carcinogen exposure in the three different groups.

Effects on the Embryonic stage of development: Problems began to develop with the XPA -/- genotype 13 days after conception. These included - growth retardation - decreased liver size - embryonic anemia, resulting in a 50% mortality rate. In both XPA +/+ and XPA +/- there were no abnormalities observed in this stage of development.

Postnatal effects: All three genotypes of XPA developed very similarly until they reached 13 months old. At this time primary fibroblasts were taken from each mouse group and exposed to 4 Jm -2 of UVB light. The XPA -/- cells had a 90% mortality rate. Both the XPA +/+ and XPA +/- genotypes suffered no losses to exposure to UVB light. These results are very similar to those found in cells isolated from XP patients.

UV carcinogenesis protocol: To test the mice’s susceptibility to skin cancer all three genotypes were exposed to one (1) low daily dose of UVB light which gradually increased to 310 Jm -2 for a total of eight weeks.

Effects of UVB on skin cancer: After one week of exposure to UVB light : XPA +/+ and XPA +/- mice showed no external signs of exposure XPA -/- mice showed hyperkeratosis and necrosis on exposed dorsal areas of the skin

Effects of UVB on skin cancer: Six weeks into the experiment the evidence of damage became more evident in XPA -/-. Abnormalities in the eyes were observed in the XPA -/- knockouts, but not in the normal or heterozygous mice.

Effects of UVB on skin cancer: The UVB exposure was discontinued after 14 weeks due to the overwhelming presence of Bowenoid lesions found in the eyes of the XPA -/- mice. It was at this time that the first cancers were noticed in the XPA -/- mice. 75% of the XPA -/- mice developed at least one squamous cell carcinoma by week 25. No cancers were observed in the other two phenotypes

Experimental Results: Mice with a defect in the XPA gene (XPA -/- ) and defective in NER strongly mimic the phenotype of XP patients. These mice have become very important tools for understanding the molecular biology of skin cancer and developing strategies for its prevention.

Conclusion : XP is a hidden disease that robs its hosts of their freedom. It also is a disease that begins to effect a person at a very young age. Further XP research is necessary and important if we are to eliminate this degenerative disease.

Are there any Questions ?